Comprehensive predictive model for cerebral microbleeds: integrating clinical and biochemical markers

Area of Science:

• Neurology
• Vascular Biology
• Biostatistics

Background:

• Cerebral Microbleeds (CMBs) are key indicators of cerebral small vessel disease.
• CMBs are linked to serious neurological conditions like stroke, dementia, and cognitive impairment.
• Current clinical tools for CMB prediction and prevention are insufficient, delaying diagnosis and intervention.

Purpose of the Study:

• To develop a robust predictive model for CMBs.
• Integrate diverse clinical and laboratory parameters for enhanced early diagnosis and risk stratification.

Main Methods:

• Analysis of data from 587 neurology inpatients.
• Utilized advanced statistical methods including LASSO and logistic regression.
• Evaluated predictors like Albumin/Globulin ratio, gender, hypertension, homocysteine, Neutrophil to HDL Ratio (NHR), and stroke history.
• Validated the model using ROC curves and DCA.

Main Results:

• The predictive model showed strong performance and clinical applicability.
• Identified Albumin/Globulin ratio, homocysteine levels, and NHR as key predictors.
• ROC curve analysis and DCA confirmed the model's utility in predicting CMBs.

Conclusions:

• The developed model advances personalized management for patients at risk of CMBs.
• Addresses the need for effective predictive tools, enabling early diagnosis and targeted interventions.
• Highlights the importance of multi-factorial risk profiling in cerebrovascular disease management.